Masitinib Inhibits Hepatitis A Virus Replication

Masitinib Inhibits Hepatitis A Virus Replication

The hepatitis A virus (HAV) infection causes acute hepatitis. HAV also induces acute liver failure or acute-on-chronic liver failure; however, no potent anti-HAV drugs are currently available in clinical situations. For anti-HAV drug screening, more convenient and useful models that mimic HAV replic...

Full description

Bibliographic Details
Main Authors: Reina Sasaki-Tanaka, Toshikatsu Shibata, Mitsuhiko Moriyama, Hirofumi Kogure, Asuka Hirai-Yuki, Hiroaki Okamoto, Tatsuo Kanda
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
drug screening
HAV
HuhT7 cells
masitinib
HAV stable replicon
Online Access:https://www.mdpi.com/1422-0067/24/11/9708

Internet

https://www.mdpi.com/1422-0067/24/11/9708

Similar Items